2nd Antigen-Specific Immune Tolerance Summit 2019

Memo

As the race to generate compelling clinical data to prove the concept of antigen-specific immunotherapies gains momentum, the 2nd Antigen-Specific Immune Tolerance Drug Development Summit returns to Boston in 2019 to help large pharma, biotech, and academic researchers to overcome the complexity of auto-immune mediated disorders, expand opportunities through combination strategies and undertake a more precise and antigen-specific approach to novel drug development. KEY Features of the 2nd Antigen-Specific Immune Tolerance Drug Development Summit: World-Class Speaker Faculty from the Likes of GSK, Eli Lilly, ITN and FDACurated Learning Journey from Early Discovery to Clinical DevelopmentAn Impactful 3-Day Summit with Solution Led Case Studies from the Fields of Allergy and AutoimmunityDeep-Dive into the Crucial Challenges and Critical Decision Making to Successfully Translate Promising Strategies into Effective TherapiesCritical Strategic Discussions Focused On Expanding Opportunities Through Combination Therapies to Address Unmet Clinical NeedsIntimate Networking with Key Decision-Makers from large Pharma, Biotech and Academia Through High-Quality Discussions "This meeting will provide opportunities to network with key scientists, hear about the latest developments and state-of-the-art science in the field of immune tolerance"Antoon Van OosterhoutVP and Head Allergic Inflammation Discovery Performance UnitGSK "I look forward to participating at this summit as cross-disease and cross-discipline exchanges are critical if we are to make disease- modifying therapy a reality in type 1 diabetes"Carla GreenbaumDirector- Diabetes ProgramBenaroya Research Institute Prices: Conference + 3 Workshops Before December 14, 2018 (Drug Developers): USD 3299.0Conference + 3 Workshops Standard Price (Drug Developers): USD 4099.0Conference + 2 Workshops Before December 14, 2018 (Drug Developers): USD 2999.0Conference + 2 Workshops Standard Price (Drug Developers): USD 3799.0Conference + 1 Workshop Before December 14, 2018 (Drug Developers): USD 2599.0Conference + 1 Workshop Standard Price (Drug Developers): USD 3399.0Conference Only Before December 14, 2018 (Drug Developers): USD 2099.0Conference Only Standard Price (Drug Developers): USD 2899.0Conference + 3 Workshops Before December 14, 2018 (Academics): USD 2199.0Conference + 3 Workshops Standard Price (Academics): USD 2799.0 URLs: Inquiries: https://go.evvnt.com/323908-2?pid=5569 Brochure: https://go.evvnt.com/323908-3?pid=5569 On Tuesday March 26, 2019 at 8:00 am (ends Thursday March 28, 2019 at 5:00 pm) Venue details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, 02114, United States